Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Randy Scott, Julian Baker, Ronnie Andrews

Premium

Randy Scott will lead a new subsidiary at Genomic Health that will focus on integrating genomic data into clinical practice for patients with common and rare genetic conditions (see related story, this issue).

Scott will step down as Genomic Health's executive chairman but will remain a board member. CEO Kim Popovits will assume the role of chairman.

Scott is a founder of Genomic Health and was previously CEO of the company. He also founded Incyte, where he served in various positions including chief scientific officer; and has served as senior director of research at Invitron. He holds a BS in chemistry from Emporia State University and a PhD in biochemistry from the University of Kansas.

Genomic Health has also appointed Julian Baker to lead independent director. Baker has served on Genomic Health's board since 2001 and is a managing partner at Baker Brothers Investments. He is also a director of Incyte, Neurogen, Theravance, and Trimeris. He holds a BA in social studies from Harvard University.


Life Technologies has appointed Ronnie Andrews as president of medical sciences. Previously, he served as CEO of Clarient, where he helped integrate the company when it was acquired by GE Healthcare. He was also segment leader of GE Molecular Diagnostics. Before that, he was senior vice president of global marketing and commercial business operations at Roche Molecular Diagnostics.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.